Evaluation of community-based systems for the surveillance of day three-positive Plasmodium falciparum cases in Western Cambodia. by Cox, Jonathan et al.
Cox, J; Dy Soley, L; Bunkea, T; Sovannaroth, S; Soy Ty, K; Ngak,
S; Bjorge, S; Ringwald, P; Mellor, S; Sintasath, D; Meek, S (2014)
Evaluation of community-based systems for the surveillance of day
three-positive Plasmodium falciparum cases in Western Cambodia.
Malar J, 13 (1). p. 282. ISSN 1475-2875 DOI: 10.1186/1475-2875-
13-282
Downloaded from: http://researchonline.lshtm.ac.uk/1848657/
DOI: 10.1186/1475-2875-13-282
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
RESEARCH Open Access
Evaluation of community-based systems for the
surveillance of day three-positive Plasmodium
falciparum cases in Western Cambodia
Jonathan Cox1,2*, Lek Dy Soley3,4, Tol Bunkea3, Siv Sovannaroth3, Kheang Soy Ty5, Song Ngak6, Steven Bjorge7,
Pascal Ringwald8, Steven Mellor9, David Sintasath10 and Sylvia Meek2
Abstract
Background: Delayed clearance of Plasmodium falciparum parasites is used as an operational indicator of potential
artemisinin resistance. Effective community-based systems to detect P. falciparum cases remaining positive 72 hours
after initiating treatment would be valuable for guiding case follow-up in areas of known resistance risk and for
detecting areas of emerging resistance.
Methods: Systems incorporating existing networks of village malaria workers (VMWs) to monitor day three-positive
P. falciparum cases were piloted in three provinces in western Cambodia. Quantitative and qualitative data were
used to evaluate the wider feasibility and sustainability of community-based surveillance of day three-positive
P. falciparum cases.
Results: Of 294 day-3 blood slides obtained across all sites (from 297 day-0 positives), 63 were positive for
P. falciparum, an overall day-3 positivity rate of 21%. There were significant variations in the systems implemented by
different partners. Full engagement of VMWs and health centre staff is critical. VMWs are responsible for a range of
individual tasks including preparing blood slides on day-0, completing forms, administering directly observed therapy
(DOT) on days 0–2, obtaining follow-up slides on day-3 and transporting slides and paperwork to their supervising
health centre. When suitably motivated, unsalaried VMWs are willing and able to produce good quality blood smears
and achieve very high rates of DOT and day-3 follow-up.
Conclusions: Community-based surveillance of day-3 P. falciparum cases is feasible, but highly intensive, and as
such needs strong and continuous support, particularly supervision and training. The purpose and role of
community-based day-3 surveillance should be assessed in the light of resource requirements; scaling-up would need
to be systematic and targeted, based on clearly defined epidemiological criteria. To be truly comprehensive, the system
would need to be extended beyond VMWs to other public and private health providers.
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Background
The Thai-Cambodian border has long been considered to
be an epicentre of emerging resistance of Plasmodium
falciparum to anti-malarial drugs, including chloroquine,
sulphadoxine-pyrimethamine and mefloquine [1]. Artemisi-
nin-based combination therapy (ACT) was implemented as
the first-line treatment for uncomplicated falciparum mala-
ria in Cambodia in 2000. Artemisinin resistance, expressed
as reduced parasite clearance rates in vivo, was first de-
tected in Pailin province in 2007–2008 [2] and has re-
cently been reported in neighbouring Pursat province [3].
In late 2008 Cambodia and Thailand embarked on a joint
strategy for the containment of artemisinin-tolerant mal-
aria parasites in Southeast Asia (ARCE), which involved
the introduction or scaling up of a number of interven-
tions in key districts on both sides of the Thai-Cambodia
border [4]. Within this strategy the presence of P. falcip-
arum parasitaemia 72 hours after the initiation of treat-
ment with an ACT (i.e. at day-3) has been used as a
standard in vivo indicator of the possible presence of drug
resistance [5]. In areas considered to be at high risk of
developing artemisinin resistance (and particularly areas
bordering zones where resistance has already been de-
tected), there is a recognized need to develop surveillance
systems through which health care providers can identify
and report delayed clearance at day-3, both as a means of
monitoring geographical patterns of resistance and as a
basis for facilitating appropriate response activities [4].
Within Cambodia the ARCE strategy has supported
the National Centre for Parasitology, Entomology and
Malaria Control (CNM) in developing new approaches
to malaria surveillance and stratification. This has in-
cluded the introduction of a new system of routine case
reporting that supports incidence-based stratification of
malaria at the village level. It has also involved testing
systems for real-time, community-level reporting of
cases at the point of care using village malaria workers
(VMWs). Since its introduction in 2001, the Cambodia
VMW network has been substantially scaled up [6,7]
and today covers a total of 1,576 villages in 18 malaria-
endemic provinces (unpublished CNM data). VMWs are
primarily tasked with performing rapid diagnostic tests
(RDTs) on individuals suspected of having malaria and
with treating or referring test-positive cases according to
defined guidelines. They are also encouraged to conduct
active case detection, follow up malaria patients and dis-
seminate information on malaria preventive measures.
Between July 2010 and September 2011 a new system
using community-based VMWs to detect, treat and report
day three-positive cases of P. falciparum was piloted in se-
lected districts of western Cambodia by CNM with tech-
nical support from University Research Co. (URC), FHI
360 and the Malaria Consortium. The primary objectives
of the pilot phase were: (a) to assess the feasibility and
viability of community-based systems to capture and dis-
seminate information on day three-positive P. falciparum
cases; and, (b) to collect and analyse basic epidemiological
data relating to day three-positive P. falciparum cases. A
secondary objective was to test the viability of a SMS alert
system for providing CNM and other key stakeholders
with real-time notifications of day three-positive P. falcip-
arum cases. This paper focuses on the effectiveness of sur-
veillance activities introduced at the community level
through the VMW system.
Methods
The pilot system
Community-based surveillance systems were implemen-
ted at selected sites in Pailin, Battambang and Pursat
provinces in western Cambodia. In each province, the
pilot project was implemented by a different project
partner (CNM in Pursat, URC in Battambang and FHI
360 in Pailin). Overall, the pilot system covered a total
of 76 villages, all of which fell within ARCE containment
zone 1, an area targeted for P. falciparum malaria elimi-
nation. Pilot surveillance activities started between July
and October 2010, depending on the implementing part-
ner, and were originally scheduled to run for six months.
Delays in the start up of some activities, together with a
smaller than expected number of malaria cases at some
sites in the early months of the project, led to the pilot
period subsequently being extended to run to the end of
September 2011.
A common framework for pilot activities was agreed in
advance by the three implementing partners and as far as
possible aimed to integrate day-3 surveillance tasks within
routine VMW activities, for example by carrying out re-
fresher training, supervision and resupply of consumables
during VMW monthly meetings. Within this common
framework patients presenting to VMWs with suspected
malaria were tested using an RDT, as per the standard
VMW system. VMWs were then required to prepare thick
and thin blood films for individuals testing positive for
P. falciparum or mixed infections and to fill out relevant
sections of a project-specific case report form. Blood slides
were air-dried and stored for subsequent staining and
examination by laboratory staff at the relevant supervising
health centre. VMWs were required to administer dir-
ectly observed therapy (DOT) for all P. falciparum-
positive individuals using a standard three-day treat-
ment course of Duo-cotecxin (dihydroartemisinin-
piperaquine). In addition, VMWs were asked to prepare
a follow-up blood slide for all individuals on day-3. After
examining these slides, laboratory staff at the supervising
health centre were responsible for completing the case
report form and, in instances where the day-3 slide was
positive for P. falciparum, to send a pre-coded SMS
message to CNM using a dedicated phone number.
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Once the SMS was received by the CNM server, text alerts
with details of individual day three-positive cases were
relayed to relevant partners, including staff at district and
provincial health departments.
Within this basic framework a certain amount of flexibil-
ity was retained to allow individual implementing partners
to adjust their protocols to best suit the existing situation
on the ground. For example, details concerning the logistics
of patient follow-up (DOT and day-3 slide), the method of
transporting blood slides from VMWs to health centres,
local staffing and supervision arrangements, and staff remu-
neration were determined individually by partners. An im-
portant element of the evaluation was an assessment of the
relative importance and merit of these variations within the
overarching protocol.
The evaluation
Qualitative data relating to system performance and pro-
vider experiences were collected through a series of semi-
structured, open-response interviews with key informants.
Separate interview guides for VMWs and health facility
staff were prepared in advance on the basis of pre-
evaluation field visits. Interviews were conducted with a
cross-section of VMWs (n = 32) in 27 villages. Because
only a small minority of villages had reported P. falcip-
arum cases during the pilot phase, the selection of VMWs
was essentially non-random but was stratified in such a
way as to capture variations in village population size,
malaria case loads and accessibility. Six supervising health
facilities were also visited and all staff officially associated
with the day-3 pilots (including health centre chiefs, clin-
ical staff and laboratory staff) were interviewed. In
addition, field staff from FHI 360 and URC were inter-
viewed at provincial level and principal investigators were
interviewed at the national level.
As part of this evaluation, quantitative surveillance data
from the community-based pilot were collated and ana-
lysed. Implementing partners were asked to provide a
range of data, including information on RDT and blood
slide results and ‘process’ data relating to the timings of
blood slide preparation, transport and examination.
This evaluation was led by the Cambodia Ministry of
Health and all activities, including interviews, were con-
ducted with the full participation of, and were supervised
by, senior staff from CNM. In line with standard CNM
practice it was required that participants provide informed
verbal consent prior to interviews. The evaluation was ap-
proved by the Ministry of Health of Cambodia and consti-
tuted a core programmatic activity of CNM.
Results
Malaria case data
Table 1 presents summary data on day-0 and day-3
P. falciparum cases reported by VMWs during the pilot
period. Across all sites a total of 297 day-0 blood slides
were positive for P. falciparum, of which 28 represented
mixed infections with P. vivax. At day-3, 63 out of 294
blood slides examined were positive for P. falciparum
(additionally, two were positive for P. vivax), representing
an overall day-3 P. falciparum positivity rate of 21.4%. The
majority of day-3 P. falciparum cases (54/63; 86%) were
detected at Ta Sanh in Battambang province, where the
overall day-3 P. falciparum-positivity rate was 22%. In Pai-
lin, the day-3 positivity rate, based on a relatively small de-
nominator, was slightly higher, at 33.3% (7/21). At
Pramaoy, Pursat, of the 25 day-3 slides examined, only
two P. falciparum infections were detected at day-3 (posi-
tivity rate = 8%). No day-3 P. falciparum cases were de-
tected at Trang (Battambang). In terms of basic
demographic characteristics, 76% of day-0 P. falciparum-
infected individuals were male and 78% of P. falciparum-
infected individuals were aged 15 or over (corresponding
figures for day-3 P. falciparum cases were similar, at 70
and 79%, respectively).
Overall, fewer than half (35/76) of the villages included
in the pilot studies reported any P. falciparum cases over
the period of the project. This proportion varied sub-
stantially between sites; in Ta Sanh 85% of villages re-
ported at least one P. falciparum case, while in Pailin,
Pramaoy and Trang this figure was substantially lower
(at 50, 40 and 13%, respectively).
Based on VMW data and using village population data
collected through the ARCE containment project, spatial
patterns of malaria incidence demonstrated marked het-
erogeneity across the study area (Figure 1), with the ma-
jority of day-0 cases (245/297; 82%) being reported by
VMWs at Ta Sanh. This spatial heterogeneity was also
evident within individual study sites for both day-0 and
day-3 infections. To illustrate this point, Figure 2 shows
local spatial variations in day-0 incidence rates (Panel A)
and day-3 incidence rates (Panel B) among pilot villages
within the Ta Sanh site. Most of the villages in the north-
ern part of the catchment reported few, if any, day-0 P.
falciparum cases. Malaria incidence was highest in villages
at the southern end of the catchment, located closest to
primary forest. In two villages (Phnom Rai and Ou Non-
oung) day-0 P. falciparum incidence was around 200 cases
per 1,000 population per year. However, day-0 and day-3
incidence rates were not strongly correlated. In the case of
Ou Nonoung, for example, the day-3 positivity rate was
58%, which translated into a day-3 incidence rate of 116.8
cases per 1,000 per year. In contrast, the day-3 positivity
rate in Phnom Rai was only 7.5%, which translated into a
much lower rate of day-3 incidence of 14.9 cases per 1,000
per year (Figure 2).
Data from the pilot studies demonstrated temporal as
well as spatial clustering, particularly in terms of day-3
positivity rates. Most notably, 26 of the 54 day-3 cases
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Table 1 Site-specific summary data for day-0 and day-3 cases generated by URC, FHI 360 and CNM community pilots
URC FHI 360 CNM
Ta Sanh Trang Pailin Pramaoy Total
Villages included in pilot 13 15 28 20 76
Villages reporting Pf cases 11 2 14 8 35
Number of day-0 slides prepared 276 6 60 27 369
Number of day-0 slides P. f positive 245 4 21 27 297
Number of day-3 slides prepared 245 3 21 25 294
Number of day-3 slides P. f positive 54 0 7 2 63
Overall % day-3+ 22.0 0.0 33.3 8.0 21.4
Figure 1 Variations in village-level incidence of Plasmodium falciparum across pilot study sites in Battambang, Pailin and Pursat
provinces, Cambodia.
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reported in Ta Sanh were detected in a four-week period
between 26 September and 21 October. This translates
into 48% of the day-3 P. falciparum cases being reported
within a time-window representing 8% of the study period
(by comparison 22% of day-0 P. falciparum cases were re-
ported during the same period).
Process indicators
In order to assess operational feasibility of the systems,
data on the implementation were documented. When
compiling datasets for the community-based pilot, imple-
menting partners were asked to collate (where possible)
additional information relating to the timing of various
activities within the case reporting/management process,
including day-0 and day-3 slide preparation, slide examin-
ation and the administration of DOT. In the event not all
of these data were available from all partners. Notably, no
data relating to the timing of slide examination or treat-
ment were available for the CNM pilot at Pramaoy.
Table 2 summarizes process indicators relating to man-
agement of day-0 and day-3 slides that are common to
both the URC and FHI 360 datasets. URC data from
Trang are not included because of the very small sample
size and a relatively large number of unresolvable errors
among the dates entered. A notable feature of the data
presented for Pailin is the relatively low rate of follow-up
achieved at day-3; among 60 cases identified on day-0,
Figure 2 Local spatial patterns of incidence of Plasmodium falciparum infection at day-0 (Panel A) and day-3 (Panel B) in the
catchment of Ta Sanh health centre, Battambang province.
Table 2 Summary of key process indicators at FHI 360
and URC pilot sites
Process indicator Pailin
(FHI 360)
Ta Sanh
(URC)
Number of day-0 slides prepared: 60 276
Number of day-3 slides prepared: 21 276
Treatment initiated: Same day (day-0) 21 268
+1 day 6
day-3 slide prepared: On day-3 21 266
On day-4 - 6
Blood slides* received by
health centre:
Same day 37 242
+1 day 5 164
+2 days - 30
+ 3 days or more - 14
Blood slides* examined at
health centre:
Same day as received 35 216
+1 day 7 184
+2 days - 44
+ 3 days or more - 34
*Aggregate of both day-0 and day-3 slides. Note for FHI information on dates
of slide transport and examination are only available for 21 cases who were
successfully followed up on day-3.
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39 cases were referred to ongoing drug efficacy studies in
Pailin (using different drug regimens) and were therefore
not available for follow-up. Within the FHI 360 dataset
process, information was only available for the 21 indivi-
duals who were followed up to day-3. All appeared to have
received treatment on day-0 and all had their follow-up
day-3 slide prepared on the correct day. Within the FHI
360 system day-0 and day-3 slides were transported indi-
vidually by VMWs to the health centre to be stained and
examined. Taking data for day-0 and day-3 slides together,
88% of slides were received by the health centre on the
day they were prepared. The remaining 12% were sent the
next day. The majority (83%) of day-0 and day-3 slides ap-
pear to be have been examined on the day they were re-
ceived at the health centre, again, with the remainder
being read the following day.
Process data for Ta Sanh were similarly impressive.
The data on treatment delay probably cannot be taken
at face value, as they most likely reflected data entry
errors on the part of VMWs. Under the URC system
(and as distinct from the FHI 360 system), VMWs were
required to transport day-0 and day-3 slides together on
day-3. The majority of slides (92%) were then either
transported to the health centre on the same day or on
the following day (i e, day-four). Once received, 86% of
slides were examined at the health centre either on the
day they were received or the day after. Only a small
minority of slides (6%) had not been examined after two
days. The longest delay between a slide being received
and examined was six days.
To determine the completeness of reporting through
the day-3 surveillance system, the total number of day-0
slides prepared at each site over the course of the pilot
was compared to the total number of RDT-positive tests
reported by the same VMWs through the routine
national reporting system. For Pailin and Battambang
the number of day-0 slides examined (n = 271) matched
very closely the total number of positive RDT results re-
ported by VMWs through the routine system (n = 308),
indicating that a large proportion of P. falciparum-
positive individuals were being effectively captured by
the day-3 surveillance system. At Pramaoy, however,
only 27 day-0 slides were examined over the course
of the pilot, compared to 713 P. falciparum or mixed
infections diagnosed by RDT by the same VMWs.
This indicates that under the CNM system a very
large number of P. falciparum-infected individuals
were not being screened through the day-3 surveil-
lance system.
Experiences of implementation
As noted previously, individual day-3 surveillance pilots
were carried out within a general framework that provided
implementing partners with a significant amount of scope
to adjust their protocols according to local contextual fac-
tors, as well as their own ideas about what would work
best logistically. As a consequence, many key system char-
acteristics (e g, procedures for patient follow-up and slide
transport, staffing arrangements and use of financial in-
centives) varied considerably between partners and indi-
vidual sites.
Within this study, semi-structured interviews were
carried out with a representative cross-section of key in-
formants, including 32 VMWs and 20 staff at health faci-
lities. The purpose of the evaluation was to document the
protocols adopted by each partner, to assess how these
were interpreted and implemented on the ground and to
gather feedback on the experience of implementing the
day-3 system. While it is not within the scope of this paper
to provide an exhaustive description of the evaluation
findings, the following sections provide an overview of the
principal variations between the partners’ protocols and a
summary of the key areas of feedback received from staff
involved with the implementation of these protocols.
Remuneration of VMWs and health facility staff
The size and type of payments made to VMWs and health
facility staff varied significantly between implementing
partners. Under the FHI 360 and URC systems VMWs re-
ceived payments for transporting day-0 and day-3 slides to
their supervising health centre (between $2 and $8 per
trip, depending on distance). Under the FHI 360 system
VMWs were paid an additional $0.25 for each blood slide
obtained but no payments were made to cover travel asso-
ciated with patient follow-up (for DOT or the day-3 slide)
or for communication. Under the URC system VMWs did
not receive a per-slide payment but were provided with $4
per case to cover travel to provide DOT (i e, $2 per visit),
plus $2 per month for communication. Within the CNM
pilot system VMWs were entitled to a flat-rate payment of
$5 per month to cover all day-3 surveillance activities and
associated travel, although in practice this was not always
received.
Financial arrangements also varied at supervising health
centres. Under URC, laboratory staff (only) received a $5
monthly payment to cover communication costs but no
payments were made for slide examination. Under FHI
360, supervising health centres were allocated $2 per
month for communication and laboratory staff received
$0.25 per blood slide examined, costings which were
based on consultation with VMWs and health centre staff
prior to the pilot. No direct payments were made to health
centre staff under the CNM system.
None of the VMWs interviewed considered payments
provided through the day-3 system to constitute an
‘incentive’ to carry out the extra tasks involved. At Ta
Sanh and Pailin the prevailing view was that rates of
travel-related compensation were realistic but did no
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more than cover actual costs incurred. Where extra pay-
ments were made for slide preparation (under FHI 360),
these were universally seen as being insufficient com-
pensation given the amount of work involved. Instead a
large majority of the VMWs and health centre staff
interviewed alluded to the importance of non-financial
motivating factors, including increased knowledge, trai-
ning and the opportunity to better serve their communi-
ties. Most VMWs felt that the main benefit of the pilot
was the provision of better case management to people
in their communities.
Slide preparation and transport
All VMWs in pilot villages received initial training on
blood slide preparation and were required to prepare
smears for all patients testing positive for P. falciparum or
mixed infections by RDT. The majority of VMWs inter-
viewed in Pailin reported some previous experience in
preparing slides but this was not the case for VMWs in
Battambang and Pursat. By the end of the pilot all VMWs
interviewed stated that they were willing to prepare blood
slides but the majority felt that they needed additional
training and/or practice. The consensus among laboratory
staff was that although there were a number of problems
with VMW smears at the beginning of the pilot (typically
an inappropriate quantity of blood), slide quality improved
over the course of the project. At Ta Sanh, where a system
of refresher training linked to routine VMW meetings was
introduced, the microscopist estimated that by the end of
the pilot 80-90% of incoming slides could be rated as good
quality. In Pailin and Trang, where P. falciparum case
numbers were very low, VMWs and laboratory staff noted
that it was difficult to develop and maintain skills because
opportunities for practice were rare.
As noted above, a distinctive element of the FHI 360
pilot was that day-0 and day-3 slides were transported
individually, on the day of preparation, to the VMWs’
supervising health centre. Under the URC and CNM
systems VMWs were required to send day-0 and day-3
slides together (on day-3). In the event both the URC
and FHI 360 systems appeared to facilitate timely trans-
fer of blood slides (see Table 2) and, on the basis of slide
examination results for URC, the practice of transport-
ing day-0 and day-3 slides simultaneously seems to be
viable. Although no relevant process data were available
for the CNM pilot, interviews with VMWs indicated that
many slides prepared at village level were either never
transported to the relevant health centre or were only
taken at the time of the routine monthly VMW meeting.
Unlike the FHI 360 and URC systems, VMWs under the
CNM pilot were not compensated directly for the trans-
port of slides.
Many VMWs reported that obtaining day-3 slides was
challenging, as many patients were not prepared to
make an appointment to return to the VMW’s house.
Within the URC and FHI 360 systems (under which
compensation was predicated on the VMW obtaining a
day-3 slide), all VMWs stated that they were willing to
obtain follow-up slides at the patient’s house. Under the
CNM system, where a flat rate of compensation was in
place, none of the VMWs interviewed had attempted to
follow the patients up at home and, as very few patients
were willing to return to the VMW on day-3, the vast
majority of P. falciparum cases were effectively lost to
follow-up as a result.
Treatment with DOT
Among VMWs the level of awareness concerning the
importance of DOT and adherence to set treatment
schedules was consistently high across all sites. However,
there was considerable variability between (and sometimes
within) pilot sites in terms of actual provision of DOT. At
Ta Sanh, all VMWs reported carrying out DOT for all pa-
tients. This was mostly achieved through home visits, for
which VMWs were compensated directly. In Pailin, where
no compensation was linked to DOT, VMWs typically
asked P. falciparum cases to return for treatment on day-
one and day-two; the majority view was that this was only
workable because most patients lived close by. VMWs in
Pailin appeared willing to treat patients at home in a mi-
nority of cases, but felt this was only viable because cases
numbers were very low. At Pramaoy none of the VMWs
interviewed had attempted to provide DOT at the patient’s
home and only one VMW had attempted to provide DOT
through appointments at the VMW station.
A number of VMWs raised concerns about providing
DOT to migrant workers either because of practical diffi-
culties associated with tracing individuals or the relatively
high risk of individuals leaving the area before completion
of the treatment regimen. Several VMWs noted the need
for general flexibility in determining when, and when not,
to attempt DOT, based on the likelihood of successful
follow up.
Slide examination and case reporting
Process data for the FHI 360 and URC pilots (Table 2) in-
dicate that across the two sites 85% of blood slides were
examined either on the same day or the day after they
were received by the health centre (corresponding data for
the CNM pilot are not available). However, this statistic
belies a number of problems reported by health centre
staff. In Pailin, among the three health centres visited dur-
ing the evaluation one did not have trained staff capable
of examining slides and staff at another claimed to be too
busy with other ongoing activities to examine slides from
the day-3 pilot (in both cases slides were routinely trans-
ported to an alternative health centre which effectively
took on all microscopy associated with the day-3 pilot).
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Several of the laboratory officers interviewed reported be-
ing demotivated by the fact that either no incentives
(under URC and CNM), or very modest incentives (under
FHI 360), were paid for examining blood slides and one
health centre chief considered this demotivating effect to
be a serious risk to the overall viability of the day-3 sys-
tem. The majority of laboratory staff interviewed felt that
competition from other roles (often associated with more
generous incentives) to be a major constraint on their
ability to support the day-3 pilot.
Within the pilot system laboratory staff were also pri-
marily responsible for sending SMS alerts of day-3 posi-
tive cases using a pre-defined coding system. With the
exception of staff at one health centre who were unable
to send texts using a non-Khmer script, none of the in-
dividuals interviewed reported any difficulties composing
or sending the SMS.
Coordination, supervision and feedback
Arrangements for project coordination differed between
sites. Pilot activities in Battambang and Pailin were coordi-
nated by specific provincial level staff within URC and
FHI 360, respectively. All VMWs at these sites claimed to
be very satisfied with the support and supervision pro-
vided, although a substantial number complained about a
lack of feedback of individual slide results and a need for
more guidance on case management of day three-positive
individuals. Within the CNM system overall coordination
was provided by national programme staff based in
Phnom Penh and no attempt was made to introduce a
system for supervision at the provincial level. This was
reflected in feedback from VMWs in Pramaoy, the ma-
jority of whom considered the level of supervision and
support they had received to be inadequate.
Discussion
day-3 surveillance pilot activities have provided valuable
data on rates of day-3 P. falciparum positivity in key areas
of western Cambodia and also on the programmatic via-
bility of community-based systems for detecting and
reporting day-3 positive cases. The overall rate of day-3
positivity across all pilot sites was 21%, with the largest
number of both day-0 and day-3 positive cases coming
from a single site (Ta Sanh). This figure greatly exceeds
not only the 3-5% background rate of day-3 positivity that
might be expected in the absence of resistance to artemisi-
nin, but also the 3-10% range which in the past has been
seen as appropriate window for initiating containment ac-
tivities [5]. Data from these community-based pilots are
consistent with those published from therapeutic efficacy
studies [8] which suggest that in key areas of western
Cambodia rates of day-3 positivity far exceed the thresh-
old figure of 10% which has been suggested as a possible
indicator for the presence of drug resistance [4]. While
attention has been previously focused on Pailin, data from
these pilots indicate high levels of day-3 positivity are also
characteristic of parts of neighbouring Battambang.
Community case management of malaria through village
volunteers has been identified as a key mechanism for
achieving targets relating to prompt access of appropriate
malaria treatment [9] and as a prerequisite for malaria
elimination [10]. The viability of using community-based
volunteers to prescribe appropriate treatment on the basis
of RDT diagnosis has been demonstrated in a variety of
settings [11-22] and, as of 2010, 42 malaria-endemic coun-
tries have reported some degree of implementation of
RDTs at community level [9]. Cambodia has a particularly
long history of community-based diagnosis and treatment
of malaria using VMWs [7] and there is good evidence
that this has been an effective mechanism for improving
access to appropriate diagnosis and treatment [23]. In
areas of potentially emergent drug resistance the detection
and follow-up of individuals with prolonged parasite clea-
rance times would seem to be a logical and justifiable ex-
tension of the role of VMWs; however findings from this
evaluation have also highlighted the non-trivial nature of
implementing and sustaining day-3 surveillance activities.
Effective day-3 surveillance is a highly intensive activity
that introduces new roles and responsibilities (as well as
significant extra work load) to VMWs and health facility
staff. For the system to be effective patients testing positive
for P. falciparum on day-0 need to be successfully traced
and re-tested on day-3 and adherence to the relevant ACT
regimen needs to be assured through the administration
of DOT. In any event, not all of these elements were
achieved consistently at all of the pilot sites.
Results presented in the previous section focused on
key variations in protocols and experiences among dif-
ferent arms of the pilot; however a consistent finding
from interviews conducted at all sites was the very
high level of project acceptability and near universal
support for the public health rationale of the project.
There was clearly an appetite on the part of VMWs
and health centre staff to improve the quality of care
provided for malaria cases and day-3 surveillance was
seen to contribute directly to this through its
emphasis on treatment and monitoring of parasite
clearance. Notably, however, these high levels of
acceptability did not always translate into high levels
of engagement. For most VMWs and facility staff,
issues relating to existing workloads, financial incen-
tives and availability of basic supplies created practical
limits to the amount of time and effort they could
justify in supporting the project.
A clear outcome from the pilot phase has been a
strong evidence base to support the feasibility of surveil-
lance predicated on blood slides obtained by VMWs.
VMWs at all sites were willing and able to prepare blood
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films as part of their routine activity and with appro-
priate training VMWs with no relevant experience were
capable of producing good quality smears by the end
of the pilot. The amount of training input needed to
achieve this should not be underestimated, however, and
regular refresher training and supervision are required,
particularly in very low transmission settings where
VMWs have limited opportunity to practice these skills.
This is consistent with experience in Vietnam, where vil-
lage health workers are routinely expected to prepare
blood films but lack of appropriate training has been
identified as a key determinant of poor performance
[24]. It is worth noting that within the URC pilot all
refresher training was carried out within the existing
system of supervision and support via routine monthly
meetings.
Evidence from the evaluation suggests that effective
DOT is achievable but requires a high level of motivation
on the part of VMWs. There was considerable variability
between (and sometimes within) pilot sites in terms of
VMW provision of DOT. At Ta Sanh, VMWs routinely
provided DOT and travelled to patients’ houses to do so.
At all other sites arrangements were more variable, but in
practice VMWs often opted to make appointments for pa-
tients to return to the VMW station for treatment. Some
VMWs reported using accompanying friends and relatives
to administer DOT. Others clearly had never attempted to
provide DOT. Overall, the evidence points to the fact that
comprehensive provision DOT cannot be achieved unless
VMWs are provided with the resources (finance and
transport) to allow them to follow up patients at home. It
is unrealistic to expect all patients to re-visit VMWs on
the second and third day to receive treatment. Indeed,
instituting such a system would arguably be counter-
productive and increase rates of non-compliance. Any sys-
tem of DOT would also have to retain some flexibility and
autonomy on the part of VMWs as to when and where
DOT is achievable. Because under these circumstances
the universal use of DOT cannot be assured, the validity
of VMW-reported day-3 positivity rates should also be
interpreted with caution.
On the evidence of process data and user feedback there
was substantial variation between the sites in terms of the
basic operational effectiveness of the pilot system. The
most obvious distinction was between pilot activities car-
ried out under the auspices of the non-governmental or-
ganisations (URC and FHI 360) and those supervised
directly by CNM. In many ways the CNM system repre-
sented a ‘minimum’ model of implementation with com-
paratively low rates of remuneration for staff involved and
with relatively modest inputs in terms of supervision. It is
likely that the relatively smooth running of pilot activities
under URC and FHI 360 can be attributed, at least in part,
to strong supervisory support provided at the provincial
level. In contrast, some of the problems experienced at
Pramaoy could be linked to the absence of equivalent
support mechanisms below the central level. Linked to
this, it is also likely that pilot experiences were influenced
strongly by the underlying characteristics of the VMW
networks at each site. Most notably at Pramaoy, where
the pilot was particularly ineffective, a large majority
of VMWs complained about frequent (and sometimes
chronic) stock-outs of ACT and RDTs, as well as problems
with the supply of consumables for the day-3 pilot itself,
both of which were symptomatic of weak supervision. For
community volunteers the demotivating effect of such fac-
tors linked to their working environment have been clearly
demonstrated in other settings [11,25].
Given the intensive nature of day-3 surveillance, the
effectiveness of the system is linked directly to the per-
formance of VMWs and key health centre staff
(particularly laboratory staff ), which itself will reflect a
variety of individual-level and contextual factors [26,27].
Health worker motivation has been identified as an im-
portant direct and indirect determinant of performance
and is therefore considered to be a key area for interven-
tion. Previous reviews have highlighted the importance
of financial incentives; however these alone may not be
sufficient to motivate health workers [28-30], particularly
in the case of community volunteers who are by defini-
tion non-salaried. Within the current evaluation none of
the VMWs or health centre staff interviewed considered
the payments provided through the pilot system to con-
stitute an incentive. A number of VMWs pointed out
that financial considerations were not a primary factor
in their original decision to volunteer and most were
keen to highlight the satisfaction they derived from serv-
ing their community and/or to their increased level of
knowledge through training. At the same time it is clear
that realistic payments for the extra tasks are a pre-
requisite for the operational viability of VMW-centred
initiatives such as this. Although VMWs felt that pay-
ments were too low to fully compensate for the time
and effort involved, they were generally considered suffi-
cient to cover their basic costs. Most VMWs made it
clear that they would be unable to continue following up
malaria cases in the absence of these basic payments. A
number of VMWs and health centre staff also stressed
the importance of payments being linked explicitly
to specific activities such as slide transport or patient
follow-up. Within the CNM pilot it was evident that use
of a flat-rate monthly payment to VMWs was not con-
ducive to increasing levels of VMW engagement with
pilot activities. Moreover, key aspects of VMWs’ prac-
tices within the URC and FHI 360 pilots could be linked
to the payment structures used in each case. Under FHI
360, for example, VMWs were not paid to travel to pa-
tients’ houses to administer DOT and as a result patients
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were required to travel to the VMW’s house to receive
treatment. This proved to be viable in Pailin but would
not be recommended as a general model of implementa-
tion. Under URC, on the other hand, VMWs routinely
carried out active follow-up of patients and a number
stated explicitly that this would only be possible while they
received financial compensation for doing so. At both sites
compensation was contingent on a day-3 slide being sub-
mitted to the supervising health centre which no doubt
contributed to very high rates of day-3 follow-up (as dis-
tinct from experiences at the CNM site).
Typically when asked what was good about the project,
or what motivated them to be involved, VMWs focused
on improved case management. However, many felt they
were not receiving sufficient support through training,
guidance or supervision to maximize their effectiveness in
this area. It has been shown in other settings that
provision of adequate training and appropriate job-aids
are critical to health worker performance [11,20,31] and
there is a need to examine areas of best practice from
these pilots and similar studies to tailor these elements in
future. As noted above, adequate supervision is also a key
factor influencing health worker performance. This fact
is widely recognized, although supervision systems for
community volunteers are nevertheless typically weak
[27]. On a positive note, experience from the current
pilots indicates that many of the training and supervision
inputs required to support day-3 surveillance activities
can be achieved through the existing mechanism of VMW
monthly meetings. In addition, relatively small changes in
the way health centre staff provide feedback to VMWs
may produce beneficial effects. Perhaps somewhat coun-
ter-intuitively the amount of effort required to implement
and sustain day-3 surveillance activities is likely to be
greater in low transmission settings than in areas where
P. falciparum cases are relatively common.
Within the piloted systems much of the burden of
activity rests with VMWs but the viability of the system
also depends on effective engagement by key health
centre staff, and most notably laboratory staff respon-
sible for blood slide examination. Within this evaluation
feedback from laboratory staff interviewed was quite
variable, particularly regarding the importance (or other-
wise) of financial incentives. However, there was a clear
general consensus that the degree to which laboratories
could support day-3 surveillance was limited inherently
by pre-existing commitments to other projects and rou-
tine activities, and in many cases staff were reluctant to
take on extra duties. It is clear that any attempt to scale
up new surveillance activities will need to address this
constraint and, where required, strengthen laboratory
capacity. The issue of competing commitments is also
highly relevant to VMWs who in addition to their own
personal commitments are now required to treat
acute respiratory infections and cases of diarrhoea [6]
and in some cases may also be responsible for the deli-
very of other services, including maternal and child
health and family planning. It has been suggested that in
the future community volunteers may represent a suit-
able platform for community-based approaches for redu-
cing malaria transmission, including active case
detection, focused screening and treatment and targeted
focal vector control [10]. However, the capacity of
VMWs to support such activities requires careful review
prior to developing new policy in this area.
It is worth noting that in the early planning stages of the
day-3 surveillance pilots, the novel use of SMS messaging
to provide rapid alerts of day-3 P. falciparum cases to
CNM and other stakeholders was a prominent feature of
planned activities. In practice, however, this technological
element represented a very small component of the overall
work flow and any problems users had with the system (e
g, inexperience in sending texts) appeared to be entirely
tractable. It is important to recognize that within the
current day-3 framework information technology (IT) is
used essentially to increase the effectiveness of surveil-
lance data once they have been generated. IT does not
make the gathering of these data any easier. In reality the
principal impediments to achieving effective surveillance
of day-3 P. falciparum cases relate to basic health system
constraints (outlined above) and there are clear limits to
the extent that technology can support this process. In the
elimination literature there has been a tendency to see the
strengthening of surveillance systems as a technical chal-
lenge involving the deployment of new means of man-
aging and transmitting surveillance data [32-34]. Gains
from these developments will only be realised, however,
once wider health system constraints have been effectively
resolved.
On balance, evidence from this evaluation suggests
that introducing community-based systems for detecting
and reporting day-3 positive cases of P. falciparum is vi-
able, but that a number of prerequisites need to be suc-
cessfully met before such a system can be considered to
be practically feasible. At the most basic level pre-
existing local VMW-health centre networks need to be
effective, incorporating adequate supervision and resup-
ply of RDTs, drugs, slides and other consumables. Rela-
tively frequent training of VMWs is required to ensure
that slide quality is adequate and to fully empower
VMWs in the process of case management. Given the
relatively intensive nature of day-3 surveillance activities
it is essential that VMWs are directly compensated for
travel associated with obtaining and delivering blood
slides and administering DOT. Careful consideration
needs to be given to existing time commitments of both
VMWs and health centre staff and where necessary hu-
man and operational capacity needs to be strengthened
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before such add-on activities can be supported. This lat-
ter point is pertinent not only in the case of day-3 sur-
veillance but also in the wider context of using
community volunteers to support interventions aimed at
drug resistance containment and/or malaria elimination.
Conclusions
Results from pilot activities indicate that an appro-
priately resourced and well-supported community-based
system for day-3 surveillance is certainly capable of pro-
viding robust indicator data on day-3 positivity. How-
ever, on its own such a system cannot be considered
comprehensive as it fails to capture P. falciparum cases
presenting directly to government facilities or private
providers. Creating a more comprehensive day-3 surveil-
lance system would involve effective integration of
community- and facility-based systems. A suitable blue-
print for such a system is relatively easy to envisage. In
practice, however, achieving the sort of close coordi-
nation of facility- and village-based activities required to
make this work would be more challenging. The ques-
tion of whether there is proper justification for this type
of integrated system depends ultimately on the perceived
purpose of day-3 surveillance. If it is primarily to serve
as a platform for monitoring temporal changes in day-3
positivity rates then arguably an extensive sentinel site
system, most likely consisting of inpatient facilities,
would almost certainly be a more efficient and cost-
effective approach to generating suitable datasets. If the
purpose of day-3 surveillance is to identify as many P.
falciparum infections in the community as possible, and
use this information to clear these and nearby infections,
other mechanisms (e.g. FSAT) may be more appropriate.
If, however, the rationale for the day-3 system is to pro-
vide an effective alert system for identifying potential
clusters of day-3 positives, the type of system piloted in
this exercise will be potentially valuable, providing they
are appropriately targeted geographically and linked ex-
plicitly to well-defined plans for response. Whatever op-
tion is selected for scale-up, this study underlines the
importance of evaluation in assisting programmes and
donors to make rational decisions.
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